Biology-Driven Synthesis – from Marine Natural Products to Commercial Leads

Biology-Driven Synthesis – from Marine Natural Products to Commercial Leads

The project involves development of bioactive natural products into lead compounds attractive for pharmaceutical and biotechnology enterprises. The focus will be on the synthesis of new antimicrobial agents, including biofilm-inhibition and antibiotic resistance. This project is a multi-disciplinary collaboration of scientists from four Norwegian universities in Tromsø, Bergen, Stavanger and Trondheim (BiOS - The Biology-Oriented Synthesis Network) acting together with the biodiscovery centre at UiT (MabCent) - a Centre of Research Based Innovation (SFI) on “Marine Bioactives and Drug Discovery” and the associated industrial partners.

Funding agency: NFR.   




Page administrator: Bayer, Annette
Last updated: 10.11.2015 12:41